FDA Drug recall D-0787-2026
Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, St…
- FDA Drug
- Class I
- ongoing
- Published 2026-08-19
On 2026-08-19 the FDA classified a Class I recall of Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, St… by Baxter Healthcare, citing presence of Particulate Matter.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0787-2026 |
| Classification | Class I |
| Status | ongoing |
| Initiated | 2026-07-24 |
| Published | 2026-08-19 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Baxter Healthcare |
| Distribution | US |
Product
Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41.
Reason
Presence of Particulate Matter
Identifiers
| ndc | 0338-3508-41 |
|---|---|
| ndc | 0338-3503-41 |
| ndc | 0338-0096-06 |
| code_info | Lot # LD175708, Exp Date: 14-Feb-2027. |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0787-2026%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.